Both in Pharmaceuticals
Erasca vs Definium Therapeutics
Over the past year ERAS returned +56.0% and DFTX returned +112.6%; their daily moves had a correlation of 0.26.
ERAS +56.0% DFTX +112.6%Growth of $1, one year, split-adjusted
| Metric | ERAS | DFTX |
|---|---|---|
| Price | $14.91 | $32.70 |
| Market cap | $5.21B | $4.39B |
| Today | +1.84% | −2.13% |
| 1 month | +4.3% | −8.2% |
| 6 months | +36.8% | +39.6% |
| Year to date | +300.8% | — |
| 1 year | +526.5% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $268.7M | $1.05B |
| Dividend yield | — | — |
| Volatility (60d) | 59.7% | 56.9% |
| Short % of float | 14.5% | 7.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).